Physician profile
Emily Leib
NPI 1629540109
$989.28
in general payments reported to CMS, 2019-2025
15 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.63 · 2022: $384 · 2023: $174 · 2024: $157 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $153.97 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.64 | 2022 | |
| Idorsia Pharmaceuticals US INC | $105.25 | 2023 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $103.24 | 2022 | |
| Jazz Pharmaceuticals INC. | $101.29 | 2023-2025 | |
| Abbvie INC. | $85.56 | 2022-2025 | |
| Novo Nordisk INC | $63.41 | 2021-2025 | Wegovy |
| Pfizer INC. | $55.00 | 2021-2025 | |
| Dexcom, INC. | $48.19 | 2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $45.36 | 2021-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Biohaven Pharmaceutical Holding Company LTD. | $35.86 | 2022 | |
| Inspire Medical Systems, INC. | $24.03 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $16.82 | 2024 | Arexvy |
| Sanofi-Aventis U.S. LLC | $16.02 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $14.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Leib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.